Managed Account Advisors’s Boston Scientific BSX Stock Holding History

Managed Account Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$63.1M	Buy	3,562,897 +1,059,513	+42%	+$18.9M	0.05%	355
2015 Q1	$44.4M	Buy	2,503,384 +1,395,326	+126%	+$22.1M	0.04%	443
2014 Q4	$14.7M	Buy	1,108,058 +565,104	+104%	+$7.22M	0.01%	851
2014 Q3	$6.41M	Sell	542,954 -52,247	-9%	-$658K	0.01%	1258
2014 Q2	$7.6M	Sell	595,201 -23,143	-4%	-$301K	0.01%	1144
2014 Q1	$8.36M	Sell	618,344 -93,166	-13%	-$1.22M	0.01%	1057
2013 Q4	$8.55M	Buy	711,510 +398,287	+127%	+$4.71M	0.01%	1032
2013 Q3	$3.68M	Buy	313,223 +33,384	+12%	+$361K	0.01%	1395
2013 Q2	$2.59M	Buy	+279,839	New	+$2.37M	﹤0.01%	1513

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Managed Account Advisors's BSX Position: Q2 2015 in Review

Managed Account Advisors increased its Boston Scientific (BSX) stake by 42% in Q2 2015, buying an estimated $18.9M and bringing the position to 3,562,897 shares worth $63.1M. The position accounts for 0.05% of the portfolio, ranked #355.

Managed Account Advisors first reported a position in BSX in Q2 2013 and has held it in 9 quarters since. 471 funds tracked by Wall St. Rank hold BSX as of Q2 2015.

Managed Account Advisors held 3,562,897 shares of Boston Scientific worth $63.1M as of Q2 2015.
Managed Account Advisors bought 1,059,513 Boston Scientific shares in Q2 2015, an estimated $18.9M.
Boston Scientific made up 0.05% of Managed Account Advisors's portfolio in Q2 2015, its #355 holding.
Managed Account Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 9 quarters since.
471 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.